BioPharmSignal logoBioPharmSignal

Biotech News

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference

Pulse Biosciences (PLSE)Pulse BiosciencesConference / presentation

HAYWARD, Calif. --(BUSINESS WIRE)--May 8, 2026-- Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced plans to participate in the upcoming BofA Securities 2026 Healthcare Conference in Las Vegas,

Open original release

Related news

PLSEPulse Biosciences2026-05-27 20:05 EST

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

PLSEPulse Biosciences2026-04-02 20:05 EST

Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference

IARTIntegra LifeSciences2026-05-08 12:00 EST

Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference

IARTIntegra LifeSciences2026-06-02 11:30 EST

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

CVRXCVRx2026-05-27 20:30 EST

CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

ANGOAngioDynamics2026-05-27 12:30 EST

AngioDynamics to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

RXSTRxSight2026-04-29 20:10 EST

RxSight, Inc. to Present at the Bank of America Healthcare Conference

LUNGPulmonx2026-04-28 20:05 EST

Pulmonx to Present at the Bank of America Securities 2026 Health Care Conference

ANGOAngioDynamics2026-03-31 12:00 EST

AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference

SGHTSight Sciences2026-03-30 20:05 EST

Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th

View all latest news

Pulse Biosciences

Pulse Biosciences is a medical technology company focused on nano-pulse stimulation and nonthermal cellular treatments. Its platform is intended to create new ways to treat tissue while preserving surrounding structures.

Recent company news

PLSEPulse Biosciences2026-05-27 20:05 EST

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

PLSEPulse Biosciences2026-05-12 11:00 EST

ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million

PLSEPulse Biosciences2026-05-08 11:00 EST

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference

PLSEPulse Biosciences2026-05-04 11:00 EST

Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results

PLSEPulse Biosciences2026-04-25 17:00 EST

Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026

Stock data

Close
32.79 USD
Market cap
1.68B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States